
ASH 2021 Revisited: Plenary Sessions, ZUMA-7 & COVID Vaccines
In this new episode of OncTimes Talk, we revisit important sessions from the ASH 2021 Annual Meeting and interview research authors, including the primary analysis of the ZUMA-7 trial with Frederick Locke, MD, how patients with AML & MDS respond to Covid vaccine with Jeffrey Lancet, MD, and antibody response to vaccination with Susanne Saussele, MD.